Home › Funds › Soleus Capital Management, L.P. › PALI
Soleus Capital Management, L.P. position in PALI
PALISADE BIO INC · Health Care
Soleus Capital Management, L.P. reported holding 14,996,154 shares of PALI (PALISADE BIO INC) in its Q3 2026 13F filing — a position valued at US$20.2M, representing 0.72% of its reported portfolio and ranking #33 among its reported holdings. Soleus Capital Management, L.P. has disclosed PALI holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s PALI position evolved
Soleus Capital Management, L.P. first disclosed a stake in PALI in Q2 2026 at 13,063,687 shares (US$27.3M). Across 2 filings, Soleus Capital Management, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 14,996,154 shares valued at US$20.2M — an increase of 1,932,467 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 13.06M | $27.30M | New |
| Q3 2026 | 15.00M | $20.24M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PALI and 13F data
PALI (PALISADE BIO INC) is a Health Care company. 75 other funds we track also report a position in PALI — the largest reported positions include B Group, Inc. (US$15.4M), Octagon Capital Advisors LP (US$13.9M), Boxer Capital Management, LLC (US$6.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PALI
- B Group, Inc. 11.41M sh · $15.41M · Q3 2026
- Octagon Capital Advisors LP 10.28M sh · $13.87M · Q3 2026
- Boxer Capital Management, LLC 4.80M sh · $6.48M · Q3 2026
- Squadron Capital Management LLC 3.00M sh · $4.05M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 2.34M sh · $3.15M · Q3 2026
- Propel Bio Management, LLC 2.22M sh · $3.00M · Q3 2026
- PLATINUM INVESTMENT MANAGEMENT LTD 2.18M sh · $2.95M · Q3 2026
- Creek Drive Management Group LLC 680.00K sh · $918.00K · Q3 2026
- ACT CAPITAL MANAGEMENT, LLC 307.50K sh · $642.67K · Q2 2026
- ACT Capital Partners, L.P. 307.50K sh · $415.12K · Q3 2026
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held PALI?
Soleus Capital Management, L.P. has disclosed PALI holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Soleus Capital Management, L.P.'s current position in PALI?
As of Q3 2026, Soleus Capital Management, L.P. holds 15.00M shares of PALI (PALISADE BIO INC), valued at $20.24M, representing 0.72% of its reported portfolio and ranking #33.
Has Soleus Capital Management, L.P. been buying or selling PALI?
In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. increased its position in PALI.
Which other funds hold PALI?
Other major institutional holders of PALI include B Group, Inc., Octagon Capital Advisors LP, Boxer Capital Management, LLC, among 75 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.